Leah Fink

584 citations
15 papers · 403 indexed · h-index 8
Topics
Multiple Myeloma Research and Treatments (11 papers)Cancer Treatment and Pharmacology (6 papers)Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers)

In The Last Decade

Leah Fink

14 papers receiving 397 citations

Peers

Leah Fink
Comparison fields: 5 of 38
  • Hematology 379
  • Molecular Biology 277
  • Oncology 228
  • Genetics 59
  • Pathology and Forensic Medicine 14
Replace Paul Schoen with:
Paul Schoen United Kingdom
Faiza Zafar United States
Kathleen Colson United States
Lela M. Lucy Italy
Amani Kitali United States
Robin Carson United States
Bonnie Jenkins United States
Nuriet K. Khuageva Russia
Trisha Piontek United States
Julie Blædel United States
Leah Fink relative to Paul Schoen United Kingdom Paul Schoen's profile →
Citations per field
00.5×1.7×
Paul Schoen · 1×
Citations per year

Countries citing papers authored by Leah Fink

Since Specialization
Citations

This map shows the geographic impact of Leah Fink's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leah Fink with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leah Fink more than expected).

Fields of papers citing papers by Leah Fink

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leah Fink. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leah Fink. The network helps show where Leah Fink may publish in the future.

Co-authorship network of co-authors of Leah Fink

This figure shows the co-authorship network connecting the top 25 collaborators of Leah Fink. A scholar is included among the top collaborators of Leah Fink based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leah Fink. Leah Fink is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
#WorkIndexed citations
1 8
2 17
3 25
4 17
5 14
6 1
7 16
8 1
9 1
10 0
11 77
12 219
13
MULTIPLE MYELOMA MANAGEMENT: OUTCOMES IN REAL-WORLD PRACTICE
1
14
MULTIPLE MYELOMA MANAGEMENT: PRACTICE PATTERNS ACROSS EUROPE
3
15 3

About Leah Fink

Leah Fink is a scholar working on Hematology, Genetics and Oncology, having authored 15 papers that have together received 403 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (11 papers), Cancer Treatment and Pharmacology (6 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers). The work is most often cited by research in Hematology (379 citations), Oncology (228 citations) and Genetics (59 citations). Leah Fink has collaborated with scholars based in Switzerland, United Kingdom and Germany. Frequent co-authors include Sebastian Gonzalez‐McQuire, Kwee Yong, María‐Victoria Mateos, Michèle Cavo, Paul Schoen, Marc S. Raab, Alain Flinois, Michel Delforge, Christoph Driessen and Lionel Karlin. Their work appears in journals such as Blood, British Journal of Haematology and BMC Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026